For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Combatting ibrutinib and venetoclax resistance in MCL and CLL: from CRISPR screens and genetic analyses towards improved treatment
Medicine
Mw. Y.J. Thus will defend the dissertation 'Combatting ibrutinib and venetoclax resistance in MCL and CLL: from CRISPR screens and genetic analyses towards improved treatment'. Supervisors are Prof. A.P. Kater and Prof. S.T. Pals. The co-supervisor is Dr M. Spaargaren.
Event details of
Combatting ibrutinib and venetoclax resistance in MCL and CLL: from CRISPR screens and genetic analyses towards improved treatment
The UvA uses cookies to measure, optimise, and ensure the proper functioning of the website. Cookies are also placed in order to display third-party content and for marketing purposes. Click 'Accept' to agree to the placement of all cookies; if you only want to accept functional and analytical cookies, select ‘Decline’. You can change your preferences at any time by clicking on 'Cookie settings' at the bottom of each page. Also read the UvA Privacy statement.